{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:45:14Z","timestamp":1774464314470,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.virusres.2022.198857","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T18:33:25Z","timestamp":1657391605000},"page":"198857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2"],"prefix":"10.1016","volume":"319","author":[{"given":"Mohsen","family":"Abdoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Shafaati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan Kazem","family":"Ghamsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Abdoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2022.198857_bib0001","first-page":"e2305","article-title":"Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: a preclinical study","author":"Abdoli","year":"2021","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2022.198857_bib0002","first-page":"130","article-title":"Determining influenza virus shedding at different time points in Madin-Darby canine kidney cell line","volume":"15","author":"Abdoli","year":"2013","journal-title":"Cell J."},{"key":"10.1016\/j.virusres.2022.198857_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: from bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virusres.2022.198857_bib0004","unstructured":"Assessment, R. R. SARS-CoV-2-increased circulation of variants of concern and vaccine rollout in the EU\/EEA, 14th update."},{"key":"10.1016\/j.virusres.2022.198857_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198058","article-title":"Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein","volume":"286","author":"Behloul","year":"2020","journal-title":"Virus Res."},{"issue":"9","key":"10.1016\/j.virusres.2022.198857_bib0006","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.198857_bib0007","article-title":"The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines","volume":"4169","author":"Chan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2022.198857_bib0008","doi-asserted-by":"crossref","unstructured":"Chan, Y.A., Zhan, S.H., 2020. Single source of pangolin CoVs with a near identical spike RBD to SARS-CoV-2. bioRxiv. doi:10.1101\/2020.07.07.184374.","DOI":"10.1101\/2020.07.07.184374"},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0009","doi-asserted-by":"crossref","first-page":"msab327","DOI":"10.1093\/molbev\/msab327","article-title":"The emergence of the spike furin cleavage site in SARS-CoV-2","volume":"39","author":"Chan","year":"2021","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jmv.27335","article-title":"Should the world collaborate imminently to develop neglected live-attenuated vaccines for COVID-19?","volume":"94","author":"Chen","year":"2021","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2022.198857_bib0011","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/CVI.00214-16","article-title":"Parenteral vaccination can be an effective means of inducing protective mucosal responses","volume":"23","author":"Clements","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2022.198857_bib0012","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1586\/14760584.2015.1078732","article-title":"Efficacy and effectiveness of live attenuated influenza vaccine in school-age children","volume":"14","author":"Coelingh","year":"2015","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-020-00763-0","article-title":"Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein","volume":"12","author":"Davidson","year":"2020","journal-title":"Genome Med."},{"issue":"12","key":"10.1016\/j.virusres.2022.198857_bib0014","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/vaccines9121499","article-title":"Nasal and salivary mucosal humoral immune response elicited by mRNA BNT162b2 COVID-19 vaccine compared to SARS-CoV-2 natural infection","volume":"9","author":"Guerrieri","year":"2021","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.virusres.2022.198857_bib0015","doi-asserted-by":"crossref","first-page":"e9610","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0016","doi-asserted-by":"crossref","first-page":"e00414","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-70827-z","article-title":"Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide","volume":"10","author":"Isabel","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0040","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/22221751.2020.1781551","article-title":"Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site","volume":"9","author":"Jin","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"7849","key":"10.1016\/j.virusres.2022.198857_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","volume":"591","author":"Johnson","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0019","doi-asserted-by":"crossref","first-page":"116","DOI":"10.20411\/pai.v6i1.441","article-title":"Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva","volume":"6","author":"Ketas","year":"2021","journal-title":"Pathog. Immun."},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0021","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/22221751.2020.1756700","article-title":"Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction","volume":"9","author":"Lau","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.virusres.2022.198857_bib0022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2022.198857_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153296","article-title":"Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-\u03baB) signaling pathway","volume":"78","author":"Ma","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.virusres.2022.198857_bib0024","series-title":"Biotechnological Applications of Cold-Adapted Organisms","first-page":"87","article-title":"Principle of cold-adaptation in the derivation of live attenuated respiratory virus vaccines","author":"Maassab","year":"1999"},{"key":"10.1016\/j.virusres.2022.198857_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101533","article-title":"Mutations of SARS-CoV-2 spike protein: implications on immune evasion and vaccine-induced immunity","volume":"55","author":"Mengist","year":"2021","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2022.198857_bib0026","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3758\/BF03194551","article-title":"On the analysis of psychometric functions: the Spearman-K\u00e4rber method","volume":"63","author":"Miller","year":"2001","journal-title":"Percept. Psychophys."},{"key":"10.1016\/j.virusres.2022.198857_bib43","series-title":"Vaccine Analysis: Strategies, Principles, and Control","author":"Nunnally","year":"2015"},{"issue":"66","key":"10.1016\/j.virusres.2022.198857_bib0028","doi-asserted-by":"crossref","first-page":"eabj5129","DOI":"10.1126\/sciimmunol.abj5129","article-title":"Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA","volume":"6","author":"Oh","year":"2021","journal-title":"Sci. Immunol."},{"issue":"39","key":"10.1016\/j.virusres.2022.198857_bib0029","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1016\/j.vaccine.2021.08.018","article-title":"Could live attenuated vaccines better control COVID-19?","volume":"39","author":"Okamura","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2022.198857_bib0030","doi-asserted-by":"crossref","unstructured":"Pradhan, P., Pandey, A. K., Mishra, A., Gupta, P., Tripathi, P. K., Menon, M. B., Kundu, B., 2020. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. BioRxiv. doi:10.1101\/2020.01.30.927871.","DOI":"10.1101\/2020.01.30.927871"},{"issue":"4","key":"10.1016\/j.virusres.2022.198857_bib0031","doi-asserted-by":"crossref","first-page":"e01415","DOI":"10.1128\/mBio.01415-21","article-title":"SARS-CoV-2 bearing a mutation at the S1\/S2 cleavage site exhibits attenuated virulence and confers protective immunity","volume":"12","author":"Sasaki","year":"2021","journal-title":"Mbio"},{"issue":"4","key":"10.1016\/j.virusres.2022.198857_bib0032","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/vaccines8040584","article-title":"Cold-adapted live attenuated SARS-Cov-2 vaccine completely protects human ACE2 transgenic mice from SARS-Cov-2 infection","volume":"8","author":"Seo","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0033","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/22221751.2020.1813636","article-title":"Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach","volume":"9","author":"van Tol","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.virusres.2022.198857_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-52768-7","article-title":"Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1\/S2 junction of the spike protein","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2022.198857_bib0036","series-title":"Proceedings of the National Academy of Sciences","article-title":"Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy","volume":"118","author":"Wang","year":"2021"},{"key":"10.1016\/j.virusres.2022.198857_bib0037","series-title":"Laboratory Biosafety Guidance Related to Coronavirus Disease 2019 (COVID-19): Interim Guidance","year":"2020"},{"issue":"12","key":"10.1016\/j.virusres.2022.198857_bib0038","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2022.198857_bib0034","doi-asserted-by":"crossref","unstructured":"Zhang, A. J., Chen, H., 2020. Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1\/S2 junction of the spike protein. BioRxiv. doi:10.1101\/2020.08.24.264192.","DOI":"10.21203\/rs.3.rs-78635\/v1"},{"key":"10.1016\/j.virusres.2022.198857_bib0041","article-title":"Advantageous non-specific effects of live-attenuated vaccines in COVID-19 treatment","volume":"16","author":"Yaqinuddin","year":"2021","journal-title":"Afr. J. Respir. Med."},{"key":"10.1016\/j.virusres.2022.198857_bib42","doi-asserted-by":"crossref","unstructured":"Xi, J., Lei, L.R., Zouzas, W., April Si, X., 2021. Nasally inhaled therapeutics and vaccination for COVID\u201019: developments and challenges. MedComm. 2(4), 569-586. doi:10.1002\/mco2.101.","DOI":"10.1002\/mco2.101"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817022200185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817022200185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:16:59Z","timestamp":1759155419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817022200185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"alternative-id":["S016817022200185X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198857","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198857"}}